vimarsana.com
Home
Live Updates
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023 : vimarsana.com
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023 : vimarsana.com
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
• Preliminary results of NATHALI-01 and updated results of BALLI-01 Phase I clinical studies presented at the American Society of Hematology 65th Annual Meeting • Execution of strategic...
Related Keywords
New York ,
United States ,
France ,
Paris ,
France General ,
Maryland ,
North Carolina ,
Baltimore ,
Raleigh ,
French ,
American ,
Bingc Wang ,
Pascalyne Wilson ,
Arthur Stril ,
Allogene Allo ,
Annick Schwebig ,
Ashleyr Robinson ,
Marc Dunoyer ,
Patricia Sosa Navarro ,
American Society Of Gene ,
Az Holdings ,
European Hematology Association ,
Calyxt Inc ,
Az Holding ,
Methods Clinical Development ,
Securities Exchange Commission ,
American Society Of Hematology ,
Society For Immunotherapy Of Cancer ,
Nasdaq ,
Additional Ordinary Shares Of The Company ,
Cibus Global ,
Group Share ,
International Financial Reporting Standards ,
European Investment Bank ,
Astrazeneca Holdings Az ,
Astrazeneca ,
Cibus Inc ,
European Society Of Gene ,
Allogeneic Car Development Programs ,
Barclays Capital Inc ,
American Association For Cancer Research ,
Research Data Preclinical Programs ,
International Accounting Standards Board ,
International Society For Cell ,
Cellectis The Company Euronext Growth ,
American Society ,
Cellecti Board ,
Euronext Growth ,
Annual Meeting ,
Cell Therapy ,
Editing Process ,
Gene Correction ,
Gene Insertion ,
Molecular Therapy ,
American Association ,
Cancer Research ,
International Society ,
Gene Therapy ,
European Society ,
Frontiers Bioengineering ,
Clinical Development ,
Investment Agreements ,
Collaboration Agreement ,
Astrazeneca Ireland ,
Initial Investment Agreement ,
Astrazeneca Holdings ,
Subsequent Investment ,
Subsequent Investment Agreement ,
Additional Investment ,
Initial Investment ,
Tyrell Rivers ,
Chronic Lymphocytic Leukemia ,
Annual Report ,
Depository Shares ,
Cibus Merger ,
Finance Contract ,
Astrazeneca Initial Investment ,
Astrazeneca Collaboration Agreement ,
Net Income ,
Regarding Use ,
Nasdaq Global Market ,
Private Securities Litigation Reform Act ,
Sosa Navarro ,
Chief Business Officer ,
Lifesci Advisors ,
Chief Financial Officer ,
Markets ,